Other · developed by Theriva Biologics
SYN-020 is an oral formulation of intestinal alkaline phosphatase, supplied as enteric-coated, delayed-release pellets in a capsule. It is being studied in radiation enteritis, a bowel injury caused by radiation therapy.
Summary written with AI from the sources listed at the end of this page.
| Trial | Phase | Condition | Status | Sponsor |
|---|---|---|---|---|
| NCT04815993 | Phase 1 | Enteritis Caused by Radiation (Disorder) | Completed | TOVX |
Trials of the companies BioRadar tracks, from ClinicalTrials.gov, most advanced phase first.
Enteritis Caused by Radiation (Disorder)
Updated Nov 1, 2026. Something wrong or missing? Report it on the TOVX page.
See TOVX's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
TOVX catalysts and pipeline →